Mandate

Vinge advises Main Capital in connection with the sale of Assessio

September 01, 2023 M&A

Vinge advises Main Capital V (“Main Capital”) in connection with the sale of Assessio International Holding 2 AB and its subsidiaries (“Assessio”)

Assessio is a SaaS company specialising in strategic HR and develops tests and tools within work psychology. Their tools can, among other things, help organisations predict who has the best potential to succeed in a role, find future leaders in the organisation and help define their organisational culture and match it with the individuals’ values.

Main Capital acquired Assessio in 2019, and since then, Assessio has doubled its revenue and is today the leading player in talent assessment in both the Nordics and Benelux, with over 1,800 customers across a wide range of industries.

Vinge’s team mainly consisted of Jonas Johansson, Filip Öhrner, Maria Dahlin Kolvik, Per Kling, Stina Bengtsson, Gustav Persson, Johan Gavelin, Sophie Böje, Alexander Rüdén and Anna Ekdahl Roos.

Related

Vinge advises ABGSC in connection with EQL Pharma’s inaugural bond issuance

Vinge has advised ABG Sundal Collier in connection with EQL Pharma AB (publ)’s ( “EQL”) inaugural issuance of SEK 350,000,000 senior secured bonds within a framework of up to SEK 700,000.
January 24, 2025

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in the divestment of shares in Marshall Group

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in connection with the divestment of shares in Marshall Group AB (publ) (”Marshall Group”) to HongShan Group, formerly known as Sequoia China. The Marshall Family will continue as owner in the Marshall Group.
January 24, 2025

Vinge represents Sedana Medical AB in the acquisition of Innovatif Cekal

Vinge has represented Sedana Medical AB (publ) in connection with the acquisition of Innovatif Cekal. Innovatif Cekal, based in Klang near Kuala Lumpur, Malaysia, is a manufacturer of medical devices. This acquisition enhances Sedana Medical's control over its supply chain and improves profitability through reduced cost of goods.
January 22, 2025